retatrutide commercial name just posted Phase 3 trial results showing up to 30% body weight loss over 80 weeks. That is approaching bariatric surgery territory, from a medication. It targets three hormone pathways: GLP-1 Other Names for Retatrutide: INN,

Members have access to care teams that receive 200+ hours of ongoing annual training on topics like: identity & health equity, SDoH and behavioral health for care teams, as well as additional resources, such as: Budget friendly recipes in English & Spanish Audio lessons Topic-based communities Food access program recommendations Education on Safe Spaces to live, eat, sleep, play and pray, etc

The IPGTTs were performed (glucose 2 g kg 1 i.p.) 5 min, 30 min, 2 h or 4 h after dosing and blood glucose was measured at different time points after the glucose challenge

In one study, participants using a GHK-Cu copper peptide formula experienced visible skin appearance improvements over the course of a month compared to other formulations evaluated in the same trial

The Retatrutide vs Maridebart comparison examines another investigational metabolic compound, while ongoing research explores additional combination therapies and novel targets

After 12 weeks, the researchers noted that the group receiving L-carnitine did indeed show improvements in fatigue, with the most significant improvements seen in brain fatigue. The most significant results were in those younger than 50, those over the age of 50 with high levels of free T3, and those who had hypothyroidism due to a thyroidectomy (who were taking relatively high doses of thyroid hormone)

#PharmacyBenefits #GLP1 #SelfFundedEmployers #CostContainment #PBM Full analysis in this week's newsletter: Pharmacy Benefits Briefing - Deep dive on Substack: Benefit Blind Spots - Im involved in this space